Introduction {#sec1-1}
============

Acute respiratory distress syndrome (ARDS) is a leading cause of morbidity and mortality in intensive care unit (ICU) worldwide. Mechanical ventilation is a cornerstone in management of ARDS patients. Low tidal volume combined with adequate positive end-expiratory pressure (PEEP) has been shown to reduce mortality.\[[@ref1][@ref2]\] An open lung or lung volume recruitment maneuver (LVRM) is a procedure to recruit collapsed alveoli. It may be achieved by a brief raising of transpulmonary pressure to higher levels than that achieved during normal ventilation.\[[@ref3][@ref4]\] It has been recommended as a useful tool to re-open collapsed lung regions, promoting homogeneity within the lungs, and eventually improve oxygenation. Recent review including our previous work had shown that using high frequency oscillatory ventilation (HFOV) was better, less barotraumas and unlikely to cause harm compared to conventional ventilation (CV).\[[@ref5][@ref6][@ref7]\] It is characterized by the rapid delivery of small tidal volume of gas combined with high mean airway pressure (mPaw). Thus, it may be an ideal model for lung protective strategy.

Although several experimental studies have shown a positive effect of LVRM on oxygenation, clinical studies are currently controversies. Two recent randomized control clinical trials in adult ARDS have failed to show benefits of its use compared to CV.\[[@ref8][@ref9]\] Too high intrathoracic pressures applied during LVRM to expand the collapsed lung unit may cause further barotraumas as well as biological sequelae such as cytokines upregulation, and translocation may have clinical deterioration occurring following LVRM.\[[@ref10][@ref11]\] In addition, suboptimal technique, inadequate sedation, and muscle relaxant or uncontrol of fluid balance could be responsible for this failure.\[[@ref12][@ref13]\] Thus, it was our desire to study the clinical benefits of using LVRM with HFOV compared with CV with LVRM in children with severe ARDS.

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Design {#sec3-1}

This was a prospective, randomized control trial. Our study was registered as a control--clinical trial (ISRCTN No. 64665281).

### Study population {#sec3-2}

Eighteen children (\>1 month and \<15 years of age) with diagnosis of severe ARDS (PaO~2~/FiO~2~ \<100) by Berlin definition who were admitted to our pediatric ICU (PICU) with no exclusion criteria were enrolled to our study during July 2012--December 2013. The PICU is a 10-bedded unit in the tertiary care referral center. They were enrolled by blocked randomization before start of the study. Nine children were randomly to CV with LVRM, and another nine children were allocated to HFOV with open lung technique group.

HFOV protocol used in this study was approved by our Institutional Review Board. Informed consents were obtained from the parents prior to their evaluation for HFOV therapy. Before randomization to the treatment arm, all patients were received CV with the FiO~2~ of 1, the median PEEP of 12 cm H~2~O, fluid resuscitation to keep high central venous pressure (CVP) (range between 8 and 12 mmHg) and were mostly on either inotropics or vasopressors at the time of LVRM with either CV or HFOV. All patients were deeply sedated and paralyzed.

Patients were diagnosed as ARDS by Berlin definition \[[@ref14]\] and met the following entry criteria: (1) Respiratory failure not fully explained by cardiac failure or fluid overload, (2) chest X-ray findings of new infiltrates consistent with acute pulmonary parenchymal disease, and (3) full face-mask, bi-level ventilation or continuous positive airway pressure \>5 cm H~2~O. Our exclusion criteria included the following: (1) Evidence/suspect of congestive heart failure, or (2) evidence of left atrial hypertension, or (3) Severe irreversible neurological injury or intractable shock, or (4) the underlying disease was deemed irreversible or ARDS \>48 h, and (5) Preexisting air leak syndrome (e.g., pneumothorax or pneumomediastinum) or preexisting cystic lung disease.

Oxygenation index (OI) = mPaw × FiO~2~ × 100/PaO~2~

### Ventilator strategy {#sec3-3}

We used either a SensorMedics (3100A/B) oscillator (VIASyS, USA) with a rapid high lung volume recruitment protocol as described previously.\[[@ref15]\] In brief, this strategy aims to recruit and stabilize the majority of collapsed alveoli. Starting mPaw at 30 cm H~2~O (or used 35 cm H~2~O for subjects body weight \[BW\] \>35 kg), the continuous distending pressure was sustained for 20 s (or 30 s for subjects BW \>35 kg). Then, the piston started together with gradually weaned down mPaw to the target level (+5--8 cm H~2~O above previous mPaw of CV), and other ventilator settings were adjusted accordingly base on clinical response. The initial pressure amplitude was set at 3 × mPaw of continuous mandatory ventilation (CMV), and frequency was set according to age. The fraction of inspired oxygen (FiO~2~) was gradually reduced stepwise to keep SpO~2~ above 92%. The LVRM procedure was repeated if SpO~2~ was below 95% with FiO~2~ of 1. After 1 h, the initial arterial blood gas was obtained and ventilator settings were adjusted accordingly. Hypotension was defined as a 25% decreased in baseline mean arterial pressure (MAP).

Nine children were enrolled to CV with lung volume recruitment by using either Servo I or Bennett 840 ventilators as per protocol. LVRM protocol combined with HFOV or CV were used in all the studies patients (use of 15--20 cm H~2~O of PEEP, driving pressure of 20 cm H~2~O, with 2 min decremental PEEP titrate down in each step to get the best compliance, and then set + 2 cm H~2~O above that level, finally wean down positive inspiratory pressure to get 6--8 cc/kg of tidal volume). Baseline clinical characteristic data, oxygenation, hemodynamic parameters, and clinical outcomes were recorded during the procedure and at 1, 4, 12, 24, and 48 h after LVRM and were analyzed at the end of the study.

### Statistics {#sec3-4}

All data are presented as means ± standard deviation or median (95% confidence interval) if not normally distributed. They were compared by using nonparametric Wilcoxon signed rank test. A Friedman repeated measures analysis was used for multiple comparisons. A *P* \< 0.05 was considered statistically significant. It was performed by using SPSS version 13 (SPSS; Chicago, IL, USA).

Results {#sec1-3}
=======

Twenty-three children with severe ARDS (8 female, 15 male) were recruited to our study, and five were excluded due to our exclusion criteria. Eighteen (nine in each group) followed our LVRM protocol \[[Table 1](#T1){ref-type="table"}\]. Their baseline demographic, clinical characteristics are listed and there is no statistically significant compared between HFOV and CV group \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\]. Their age was 47.7 ± 61.2 (month) and BW was 25.3 ± 27.1 (kg).

###### 

Demonstrate baseline, clinical characteristics in children enrolled in this study (*n*=18)

![](IJCCM-20-72-g001)

###### 

Compare baseline clinical characteristics between high frequency oscillatory ventilation group and conventional ventilation group. There is no statistical significant between two groups at baseline

![](IJCCM-20-72-g002)
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### Basic hemodynamic responses during lung recruitment maneuver {#sec3-5}

Change of heart rate, mean arterial pressure, and central venous pressure during lung recruitment maneuver

Before the LVRM intervention, all patients were stabilized (with fluid resuscitation and inotropes per protocol). All of them were received vasopressors based on their hemodynamic conditions. The MAP was somewhat lower at 5--10 min after LVRM but no statistically significant. Heart rate (HR) tended to lower at 60 min compare to baseline (140.4 ± 15.9 beat/min, 132.3 ± 18.5 beat/min, *P* = 0.1). There was no significant difference in HR, CVP, or MAP compared between both groups at baseline \[[Figure 1](#F1){ref-type="fig"}\].

![Demonstrate delta change in VS (heart rate, mean blood pressure, central venous pressure) after lung volume recruitment (*n* = 18)](IJCCM-20-72-g003){#F1}

### Oxygenation responses after lung volume recruitment maneuvers {#sec3-6}

All of the enrolled patients followed with the LVRM protocol at the initiation of HFOV or CV. Our primary outcome demonstrated that most of the patients in both groups were response to LVRM after 1 h ([Figure 2](#F2){ref-type="fig"}, 12/18 \[66%\]). Furthermore, 7/9 (77%) of HFOV group and 5/9 (55%) of CV group were significantly increase in PaO~2~/FiO~2~ following 1 h of lung recruitment. HFOV group had better PaO~2~/FiO~2~ response compared to CV with LVRM (138.5 ± 49.7, 69 ± 56.8%, *P* \< 0.01), \[[Figure 3](#F3){ref-type="fig"}\]. In addition, 6/9 (66%) children in CV group were failed to wean oxygen requirement lower than FiO~2~ of 0.6 after LVRM and had to switch to HFOV mode at 6 h after enrollment (two patients had refractory hypoxemia and 1 patient had refractory hypercapnia). There was no significant difference in PaO~2~/FiO~2~ ratio at 4 h compared between both groups \[[Figure 4](#F4){ref-type="fig"}\]. There was no significant change in PCO~2~ after 1 h, 4 h, 6 h, 12 h, and 24 h after LVRM.

![Demonstrate percentage change of PaO~2~, percentage change of oxygenation index and alveolar-arterial gradient after 1 h of lung volume recruitment maneuver (*n* = 18)](IJCCM-20-72-g004){#F2}

![Demonstrate significant increase of PaO~2~ after 1 h of lung volume recruitment maneuver compare between high frequency oscillatory ventilation and conventional ventilation (*P* \< 0.001, *n* = 9 each group)](IJCCM-20-72-g005){#F3}

![Significant increase of PaO~2~/FiO~2~ after 1 h of lung volume recruitment maneuver compare between high frequency oscillatory ventilation and conventional ventilation (*P* \< 0.01, *n* = 9 each group)](IJCCM-20-72-g006){#F4}

### Transition from high frequency oscillatory ventilation to conventional ventilation {#sec3-7}

Eleven patients (91%) (8/9 from HFOV and 3/9 cross-over from CV) were able to switch back from HFOV to a CV according to our transitional criteria. OI was significantly decreased at 24 h in patients who were able to switch back to CV compared to ones who were not (17.8 ± 7.2, 29.8 ± 29.9, *P* = 0.007) \[[Figure 5](#F5){ref-type="fig"}\].

![Demonstrate significant reduction in oxygenation index after 24 h of lung volume recruitment maneuver compare between high frequency oscillatory ventilation and conventional ventilation group (*P* \< 0.01)](IJCCM-20-72-g007){#F5}

### Complications and outcomes {#sec3-8}

There was no serious complication following LVRM procedure from both HFOV and CV. Most of our patients tolerated the study protocol well. No significant hemodynamic disturbance was observed. Two patients were expired (one from each group). Our PICU mortality rate of severe ARDS was 11% (2/18). The cause of death was multiple organ failures. Patients were on HFOV for a median of 6 days and had 15 ± 3.5 total days on ventilator. No patient was withdrawn from the protocol.

Discussion {#sec1-4}
==========

CV with optimum PEEP combined with low tidal volume is currently a ventilator strategy that is, widely accepted as a standard therapy for ARDS. HFOV is an alternative mode of mechanical ventilator that helps to improve oxygenation. A recent consensus management of pediatric ARDS is recommended to use HFOV with incremental LVRM in severe form. It is, however, different than our technique that used decremental LVRM. Our previous study demonstrated applying decremental lung volume recruitment together with HFOV is effective and well-tolerated in pediatric ARDS. Recent publication investigated in adult ARDS failed to demonstrate benefit of using HFOV compared to CV. Nevertheless, there were lots of pitfalls regarding these particular trials and required further study. At present, there are very few studies involving LVRM in children, and there is none compared HFOV with CV in the same trial. Our study is the first prospective randomized control trial in severe Pediatric ARDS investigated clinical outcomes compared between HFOV and CV with decremental LVRM. We found a rapid and significant improvement in gas exchange evidence by improving PaO~2~/FiO~2~ (138 ± 49.7, 69 ± 56.8%, *P* \< 0.05) and significant reduced oxygen requirement at 1 h after LVRM compared to CV. It is also in agreement with recent report from neonate and some adult studies.\[[@ref14][@ref16][@ref17]\] There was no significant difference in basic hemodynamic data compare between HFOV and CV following LVRM.

Ferguson *et al*. was the first to explore the benefit of using HFOV combined with decremental LVRM protocol in adult ARDS.\[[@ref16]\] They showed that using combination of HFOV with LVRM resulted in rapid and sustained improvement of oxygenation. Tingay *et al*. and De Jaegere *et al*. also demonstrated significant improvement in oxygenation by utilizing HFOV with LVRM in neonatal RDS whereas using different techniques.\[[@ref17][@ref18]\] Recent large multicenter clinical trials in adult ARDS has failed to demonstrate benefit of using HFOV over CV with LVRM protocol. This may explain the difference in physiologic alteration during HFOV in adult patients with ARDS or suboptimal technique of using HFOV. In general, patients who are on HFOV would require high dose of sedation and often need paralysis to ensure synchronize in ventilation. Both of these particular trials used muscle relaxant in only 50% of their patients. This common practice could make hemodynamic together with oxygenation in these patients more fluctuation and difficult to control. It also would lead to increase requirement of fluid bolus and vasopressors. The fixed oxygenation/mPaw table is also troublesome. In addition, more positive fluid balance is well known for increasing morbidity and mortality in patients with ARDS.

An open lung approach with higher levels of PEEP together with lung volume recruitment with protective ventilation strategy in CV should increase the end-expiratory lung volume through alveolar recruitment to avoid cyclic alveolar derecruitment. There were several reports of clinical responses following LVRM in ARDS patients,\[[@ref19][@ref20]\] but there was very few in pediatrics. Moreover, its benefit and clinical efficacy have not been compared with HFOV in children with severe ARDS. Another recent publication strongly demonstrated the efficacy of HFOV over CV in management of extremely premature newborn with RDS by showing those who received HFOV had superior lung function at 11--14 years of age. Our ARDS mortality in this trial is at 11% (2/18) which is better compared to recent report from ESPNIC group (17%).\[[@ref21]\] Three (3/9, 33%) patients in CV group had to cross-over to HFOV group and could eventually extubated. Thus, our study confirmed the clinical benefit of using HFOV in neonatal or children with severe respiratory failure.\[[@ref22]\] However, this study had some limitations such as our small sample size and represented only one center.

Conclusions {#sec1-5}
===========

This study showed the oxygenation benefit of using HFOV over CV with LVRM in severe pediatric ARDS. There is no significant effect on hemodynamic parameters. Furthermore, no serious complication was noted.
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